Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 113 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 188 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 170 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 100 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 95.2 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 65.8 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 53 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 58.1 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 0.0 | BCD100427B001 | 74.1 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 0.5 | BCD100427B003 | 110 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 1.0 | BCD100427B007 | 237 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 2.0 | BCD100427B011 | 115 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 4.0 | BCD100427B015 | 122 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 8.0 | BCD100427B019 | 86.1 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 12.0 | BCD100427B023 | 61.1 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | C | 24.0 | BCD100427B027 | 51.5 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 118 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 99.2 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 101 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 83.1 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 77.2 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 42.7 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 52.5 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 0.5 | BCD100427B004 | 275 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 1.0 | BCD100427B008 | 115 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 2.0 | BCD100427B012 | 257 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 4.0 | BCD100427B016 | 141 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 8.0 | BCD100427B020 | 59.3 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 12.0 | BCD100427B024 | 84.6 | pmol/sample |
| - | PE(40:8e)/PE(40:7p) | 25OH-Chol | 24.0 | BCD100427B028 | 46.1 | pmol/sample |